|
New Delhi, Jan 05: In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) chief Balram Bhargava said on Tuesday.
ICMR chief Balram Bhargava
Explaining the process followed in granting nod to Oxford COVID-19 vaccine and indigenously developed Covaxin, he said, “The existing pandemic situation, high mortality, available science and lack of definitive treatments were considered by the subject expert committee (SEC) on COVID-19 of CDSCO for granting accelerated approval to these vaccines, and that is in our legal provision.”
The Drugs Controller General of…
